e-learning resources

The regulation of IL33 following smoking cessation

A. Faiz (Ultimo (NSW), Australia), F. Boedijono (Ultimo (NSW), Australia), W. Timens (Groningen, Netherlands), M. Nawijn (Groningen, Netherlands), P. Hansbro (Ultimo (NSW), Australia), R. Mahbub (Ultimo (NSW), Australia), M. Johansen (Ultimo (NSW), Australia), C. Brandsma (Groningen, Netherlands), I. Heijink (Groningen, Netherlands), F. Massip (Berlin, Germany), M. De Biase (Berlin, Germany), R. Schwarz (Berlin, Germany), I. Adcock (London, United Kingdom), K. Chung (London, United Kingdom), P. Hiemstra (Leiden, Netherlands), H. Goulaouic (Chilly-Mazarin, France), H. Xing (Chilly-Mazarin, France), R. Abdulai (Cambridge, United States), E. De Rinaldis (Cambridge, United States), D. Cunoosamy (Cambridge, United States), S. Harel (New York, United States), D. Lederer (New York, United States), C. Nivens (New York, United States), H. Kerstjens (Groningen, Netherlands), M. Hylkema (Groningen, Netherlands), M. Van Den Berge (Groningen, Netherlands)

Source: International Congress 2022 – Translational research in COPD and lung cancer
Session: Translational research in COPD and lung cancer
 Session type: Thematic Poster
 Number: 4262

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Faiz (Ultimo (NSW), Australia), F. Boedijono (Ultimo (NSW), Australia), W. Timens (Groningen, Netherlands), M. Nawijn (Groningen, Netherlands), P. Hansbro (Ultimo (NSW), Australia), R. Mahbub (Ultimo (NSW), Australia), M. Johansen (Ultimo (NSW), Australia), C. Brandsma (Groningen, Netherlands), I. Heijink (Groningen, Netherlands), F. Massip (Berlin, Germany), M. De Biase (Berlin, Germany), R. Schwarz (Berlin, Germany), I. Adcock (London, United Kingdom), K. Chung (London, United Kingdom), P. Hiemstra (Leiden, Netherlands), H. Goulaouic (Chilly-Mazarin, France), H. Xing (Chilly-Mazarin, France), R. Abdulai (Cambridge, United States), E. De Rinaldis (Cambridge, United States), D. Cunoosamy (Cambridge, United States), S. Harel (New York, United States), D. Lederer (New York, United States), C. Nivens (New York, United States), H. Kerstjens (Groningen, Netherlands), M. Hylkema (Groningen, Netherlands), M. Van Den Berge (Groningen, Netherlands). The regulation of IL33 following smoking cessation. 4262

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.